Cancer-associated fibroblasts contribute to cancer metastasis and apoptosis resistance in human ovarian cancer via paracrine SDF-1α
Clinical and Translational Oncology · 2023
DOI: 10.1007/s12094-022-03054-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2023. Verfasst von Jie-Min Dai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, 200240, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cancer-Associated Fibroblasts. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Chongqing Science and Technology Commission Project, Hospital-level Incubation Project of The Fifth People's Hospital of Shanghai, Fudan University.
Abstract (Originalsprache)
BACKGROUND: Cancer-associated fibroblasts (CAFs), one of the main members of stromal cells in tumor microenvironment are proposed to play a central role in promoting tumor metastasis. It is unclear whether and how CAFs mediates tumor metastasis or chemoresistance in human ovarian cancer. METHODS: CAFs were extracted from human ovarian cancer tissues (OCs) of patients with different kinds of histological types. RESULTS: We found that CAFs showed more aggressive potency than those tumor cells, both of which were isolated from the same ovarian cancer specimen. Moreover, when co-cultured with CAFs, cell migration abilities of ovarian cancer cells (SKOV3, OVCAR3 and HEY) were significantly increased. Next, we preliminarily detected a higher CAFs density in sections of metastatic lesions than those in primary tumor site of primary OCs clinically. However, no significant difference of stromal derived factors-1α (SDF-1α) production from CAFs was found between primary and metastatic lesions. Additionally, in contrast with tumor cells, CAFs exhibited obvious apoptosis resistance when treated with cisplatin. Furthermore, we found that cisplatin-induced cytotoxicity and apoptosis were significantly inhibited by co-cultured with recombinant human SDF-1α in SKOV3 in a time and dose-dependent manner, and this effect was suppressed by the CXCR4 antagonist AMD3100. CONCLUSIONS: CAFs might be involved in the malignant metastasis in human ovarian cancer through promoting cell migration in tumor cells. And their resistance to cytotoxic agents might be mediated by paracrine SDF-1α/CXCR4 signaling in ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, 200240, China.
- Department of Obstetrics and Gynecology, First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
- Department of Obstetrics and Gynecology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, 200240, China. linayang12@fudan.edu.cn.
- Department of Obstetrics and Gynecology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, 200240, China. 13321837079@163.com.
Förderung
- Chongqing Science and Technology Commission Project
- Hospital-level Incubation Project of The Fifth People's Hospital of Shanghai, Fudan University
Zitieren
APA
Dai, J. M., Sun, K., Li, C., Cheng, M., Guan, J. H., Yang, L. N., & Zhang, L. W. (2023). Cancer-associated fibroblasts contribute to cancer metastasis and apoptosis resistance in human ovarian cancer via paracrine SDF-1α. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-022-03054-9
Vancouver
Dai JM, Sun K, Li C, Cheng M, Guan JH, Yang LN, et al. Cancer-associated fibroblasts contribute to cancer metastasis and apoptosis resistance in human ovarian cancer via paracrine SDF-1α. Clinical and Translational Oncology. 2023. doi:10.1007/s12094-022-03054-9
BibTeX
@article{Dai2023,
author = {Dai, Jie-Min and Sun, Ke and Li, Chang and Cheng, Min and Guan, Jun-Hua and Yang, Li-Na and Zhang, Li-Wen},
title = {Cancer-associated fibroblasts contribute to cancer metastasis and apoptosis resistance in human ovarian cancer via paracrine SDF-1α},
journal = {Clinical and Translational Oncology},
year = {2023},
doi = {10.1007/s12094-022-03054-9}
}
EUVIMED